Cargando…

Cancer Histology and Natural History of Patients with Lung Cancer and Venous Thromboembolism

SIMPLE SUMMARY: Cancer is a widely heterogeneous disease, and the natural history of patients with cancer-associated thrombosis may differ according to the cancer site. Lung cancer is the most common malignancy, and a leading cause of death. A number of studies in the literature suggest that patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruiz-Artacho, Pedro, Lecumberri, Ramón, Trujillo-Santos, Javier, Font, Carme, López-Núñez, Juan J., Peris, María Luisa, Díaz Pedroche, Carmen, Lobo, José Luis, López Jiménez, Luciano, López Reyes, Raquel, Jara Palomares, Luis, Pedrajas, José María, Mahé, Isabelle, Monreal, Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454710/ https://www.ncbi.nlm.nih.gov/pubmed/36077663 http://dx.doi.org/10.3390/cancers14174127

Ejemplares similares

Clinical Characteristics and Outcomes of Patients with Lung Cancer and Venous Thromboembolism
por: Ruiz-Artacho, Pedro, et al.
Publicado: (2018)

Acute venous thromboembolism in patients with brain cancer: clinical course
por: Becattini, Cecilia, et al.
Publicado: (2023)

Outcomes beyond the Third Month of Anticoagulation in Patients Aged >75 Years with a First Episode of Unprovoked Venous Thromboembolism
por: Iñurrieta, Amaia, et al.
Publicado: (2018)

Analysis of clinical factors affecting the rates of fatal pulmonary embolism and bleeding in cancer patients with venous thromboembolism
por: Trujillo-Santos, Javier, et al.
Publicado: (2017)

Validation of a prognostic score for hidden cancer in unprovoked venous thromboembolism
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study
por: Trujillo‐Santos, Javier, et al.
Publicado: (2022)

Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism
por: Martínez-Urbistondo, Diego, et al.
Publicado: (2021)

Three-Month Outcomes in Cancer Patients with Superficial or Deep Vein Thrombosis in the Lower Limbs: Results from the RIETE Registry
por: Debourdeau, Philippe, et al.
Publicado: (2023)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
por: Riera-Mestre, Antoni, et al.
Publicado: (2019)

Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
por: Mahé, Isabelle, et al.
Publicado: (2015)

PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19
por: Riera-Mestre, Antoni, et al.
Publicado: (2021)

Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
por: Jara-Palomares, Luis, et al.
Publicado: (2019)

Comparison of long-term complications in cancer patients with incidental and acute symptomatic venous thromboembolism
por: Barca-Hernando, María, et al.
Publicado: (2023)

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2023)

Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study
por: Jiménez, David, et al.
Publicado: (2019)

Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model
por: Jiménez, David, et al.
Publicado: (2022)

Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
por: Farge, Dominique, et al.
Publicado: (2015)

Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
por: Borjas Howard, Jaime, et al.
Publicado: (2021)

Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study
por: Figueroa, Rocío, et al.
Publicado: (2018)

A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study
por: Marin-Barrera, Lucia, et al.
Publicado: (2019)

Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid
por: Paredes-Ruiz, Diana, et al.
Publicado: (2021)

Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study)
por: Otero, Remedios, et al.
Publicado: (2022)

Differences in Venous Thromboembolism Prevention and Outcome between Hospitalized Patients with Solid and Hematologic Malignancies
por: Figueroa, Rocío, et al.
Publicado: (2019)

D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis
por: Jara-Palomares, Luis, et al.
Publicado: (2018)

Association between Radiotherapy and Risk of Cancer Associated Venous Thromboembolism: A Sub-Analysis of the COMPASS—CAT Study
por: Temraz, Sally, et al.
Publicado: (2021)

Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review
por: Moik, Florian, et al.
Publicado: (2021)

Cancer-Associated Thrombosis: Beyond Clinical Practice Guidelines—A Multidisciplinary (SEMI–SEOM–SETH) Expert Consensus
por: Pachón, Vanessa, et al.
Publicado: (2018)

Reply to comment on 'D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis'
por: Jara-Palomares, Luis, et al.
Publicado: (2019)

Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations
por: Lopez-Campos, Jose Luis, et al.
Publicado: (2015)

Screening for cancer in patients with unprovoked venous thromboembolism: protocol for a systematic review and individual patient data meta-analysis
por: van Es, Nick, et al.
Publicado: (2017)

Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry
por: Bertoletti, Laurent, et al.
Publicado: (2013)

The rationale, design, and methods of a randomized, controlled trial to evaluate the efficacy and safety of an active strategy for the diagnosis and treatment of acute pulmonary embolism during exacerbations of chronic obstructive pulmonary disease
por: Jiménez, David, et al.
Publicado: (2019)

Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?
por: Camporese, Giuseppe, et al.
Publicado: (2020)

SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death
por: Yarza, Ramón, et al.
Publicado: (2020)

A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
por: Muñoz, Andrés, et al.
Publicado: (2023)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Saddle Pulmonary Embolism in Patients with Cancer in the Era of Incidental Events: Clinical Findings and Outcomes in a Single Centre Cohort
por: Aramberri, Mario, et al.
Publicado: (2022)

Saddle Pulmonary Embolism in Patients with Cancer in the Era of Incidental Events: Clinical Findings and Outcomes in a Single Centre Cohort
por: Aramberri, Mario, et al.
Publicado: (2022)

Prognostic Impact of Active Cigarette Smoking on Mortality in Patients with Acute Venous Thromboembolic Events, Findings from Real World Data
por: Giorgi-Pierfranceschi, Matteo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_htu8r7lci0otfph0sqm8g0rlmf